• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

耐万古霉素肠球菌。

Vancomycin-resistant enterococci.

机构信息

Section of Infectious Diseases, Department of Internal Medicine and Medical Microbiology, University of Manitoba, 543-645 Bannatyne Ave, Basic Medical Building, Winnipeg, Manitoba R3E 0J9, Canada.

出版信息

Crit Care Clin. 2013 Oct;29(4):841-52. doi: 10.1016/j.ccc.2013.06.006.

DOI:10.1016/j.ccc.2013.06.006
PMID:24094380
Abstract

Vancomycin-resistant enterococci (VRE) consist mainly of Enterococcus faecalis and E faecium, the latter mostly hospital-acquired. In addition, E gallinarum and E casseliflavus are intrinsically vancomycin-resistant and are community-acquired. VRE have become common in many hospitals throughout the world and, once established, are very difficult to eradicate. VRE are difficult to treat; therefore, infection control measures in hospitals are of prime importance in preventing the establishment of these pathogens. Most severe VRE infections will need combination therapy because many of the effective antimicrobial agents, when used alone, have only a bacteriostatic effect.

摘要

耐万古霉素肠球菌(VRE)主要包括粪肠球菌和屎肠球菌,后者主要为医院获得性。此外,鸡肠球菌和黄色肠球菌固有地对万古霉素具有耐药性,且为社区获得性。VRE 在世界上许多医院已经很常见,一旦建立,就很难根除。VRE 很难治疗;因此,医院中的感染控制措施对于预防这些病原体的建立至关重要。大多数严重的 VRE 感染需要联合治疗,因为许多有效的抗菌药物单独使用时只有抑菌作用。

相似文献

1
Vancomycin-resistant enterococci.耐万古霉素肠球菌。
Crit Care Clin. 2013 Oct;29(4):841-52. doi: 10.1016/j.ccc.2013.06.006.
2
[Vancomycin resistant Enterococci (VRE)].耐万古霉素肠球菌(VRE)
Nephrol Ther. 2009 Jun;5 Suppl 4:S261-4. doi: 10.1016/S1769-7255(09)74556-0.
3
[Vancomycin resistant enterococci in Austria].[奥地利的耐万古霉素肠球菌]
Wien Klin Wochenschr. 1997 May 9;109(9):312-20.
4
[Vancomycin resistant enterococci in the Netherlands].[荷兰的耐万古霉素肠球菌]
Ned Tijdschr Geneeskd. 2004 May 1;148(18):878-82.
5
Recommendations for preventing the spread of vancomycin resistance. Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC).预防万古霉素耐药性传播的建议。医院感染控制实践咨询委员会(HICPAC)的建议。
MMWR Recomm Rep. 1995 Sep 22;44(RR-12):1-13.
6
Vancomycin-resistant enterococci. The 'superbug' scourge that's coming your way.耐万古霉素肠球菌。即将来袭的“超级细菌”灾难。
Postgrad Med. 1996 May;99(5):60-5, 69-71.
7
Outbreak of vancomycin-resistant enterococci in a tertiary hospital: the lack of effect of measures directed mainly by surveillance cultures and differences in response between Enterococcus faecium and Enterococcus faecalis.万古霉素耐药肠球菌在一家三甲医院的爆发:主要通过监测培养指导的措施缺乏效果,以及屎肠球菌和粪肠球菌之间的反应差异。
Am J Infect Control. 2010 Jun;38(5):406-9. doi: 10.1016/j.ajic.2009.08.010. Epub 2009 Dec 16.
8
Preventing the spread of vancomycin-resistant enterococci (VRE) in Canada.在加拿大预防耐万古霉素肠球菌(VRE)的传播。
Can Commun Dis Rep. 1997 Dec;23 Suppl 8:i-iv, 1-16, i-iv, 1-19.
9
[Vancomycin resistant enterococci].耐万古霉素肠球菌
Rinsho Byori. 1998 Jul;46(7):629-36.
10
Costs and savings associated with infection control measures that reduced transmission of vancomycin-resistant enterococci in an endemic setting.在地方流行环境中,与减少耐万古霉素肠球菌传播的感染控制措施相关的成本和节约情况。
Infect Control Hosp Epidemiol. 2001 Jul;22(7):437-42. doi: 10.1086/501931.

引用本文的文献

1
Fourier-transform infrared spectroscopy for typing of vancomycin-resistant : performance analysis and outbreak investigation.用于耐万古霉素分型的傅里叶变换红外光谱法:性能分析与暴发调查
Microbiol Spectr. 2023 Sep 22;11(5):e0098423. doi: 10.1128/spectrum.00984-23.
2
Bacterial resistance to antibacterial agents: Mechanisms, control strategies, and implications for global health.细菌对抗菌药物的耐药性:机制、控制策略及其对全球健康的影响。
Sci Total Environ. 2023 Feb 20;860:160461. doi: 10.1016/j.scitotenv.2022.160461. Epub 2022 Nov 23.
3
Multidrug-Resistant Bacteria: Their Mechanism of Action and Prophylaxis.
多重耐药菌:作用机制与预防。
Biomed Res Int. 2022 Sep 5;2022:5419874. doi: 10.1155/2022/5419874. eCollection 2022.
4
Practice Summary of Antimicrobial Therapy for Commonly Encountered Conditions in the Neonatal Intensive Care Unit: A Canadian Perspective.新生儿重症监护病房常见病症抗菌治疗实践总结:加拿大视角
Front Pediatr. 2022 Jul 8;10:894005. doi: 10.3389/fped.2022.894005. eCollection 2022.
5
Longitudinal Evaluation of Gut Bacteriomes and Viromes after Fecal Microbiota Transplantation for Eradication of Carbapenem-Resistant .定植粪菌治疗清除碳青霉烯类耐药肠杆菌科后肠道细菌组和病毒组的纵向评估
mSystems. 2022 Jun 28;7(3):e0151021. doi: 10.1128/msystems.01510-21. Epub 2022 Jun 1.
6
Resistance of Gram-Positive Bacteria to Current Antibacterial Agents and Overcoming Approaches.革兰阳性菌对抗菌药物的耐药性及克服方法。
Molecules. 2020 Jun 23;25(12):2888. doi: 10.3390/molecules25122888.
7
Genomic Epidemiology of Vancomycin-Resistant Enterococcus faecium (VREfm) in Latin America: Revisiting The Global VRE Population Structure.拉丁美洲万古霉素耐药粪肠球菌(VREfm)的基因组流行病学:重新审视全球 VRE 人群结构。
Sci Rep. 2020 Mar 27;10(1):5636. doi: 10.1038/s41598-020-62371-7.
8
Infectious Disease Management and Control with Povidone Iodine.聚维酮碘用于传染病的管理与控制。
Infect Dis Ther. 2019 Dec;8(4):581-593. doi: 10.1007/s40121-019-00260-x. Epub 2019 Aug 14.
9
Chinese guidelines for the diagnosis and treatment of hospital-acquired pneumonia and ventilator-associated pneumonia in adults (2018 Edition).成人医院获得性肺炎与呼吸机相关性肺炎诊断和治疗中国专家共识(2018年版)
J Thorac Dis. 2019 Jun;11(6):2581-2616. doi: 10.21037/jtd.2019.06.09.
10
Emergence of vancomycin-resistant enterococci in Switzerland: a nation-wide survey.瑞士万古霉素耐药肠球菌的出现:一项全国性调查。
Antimicrob Resist Infect Control. 2019 Jan 17;8:16. doi: 10.1186/s13756-019-0466-x. eCollection 2019.